GSK

GSK · LONDON

$50.75−$0.46 (−0.90%)TodayMarket closed · Oct 23, 7:59 PM ET

Prev close $51.21

Latest news

NewsOct 21, 10:14 AM ETVandana Singh
GSK Wins FDA Approval For Chronic Hepatitis B Drug
Press releaseOct 20, 7:58 PM ETBusiness Wire
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
NewsOct 20, 3:50 PM ET
FDA Approves First-Of-Its-Kind Chronic Hepatitis B Treatment; Approves Hibsago (Bepirovirsen) For Chronic Hepatitis B In Adults Without Cirrhosis
Press releaseOct 19, 6:18 PM ETBusiness Wire
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
NewsOct 19, 2:08 PM ETVandana Singh
FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated
NewsOct 19, 12:29 PM ET
FDA Approves Immunotherapy That May Allow Certain Patients With Rectal Cancer To Avoid Chemotherapy, Radiation And Surgery
NewsOct 19, 8:38 AM ETVandana Singh
Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push
Press releaseOct 8, 7:38 AM ETPRNewswire
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
NewsOct 8, 7:01 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
NewsSep 14, 12:03 PM ETVandana Singh
Why Is GSK Stock Gaining Monday?
NewsSep 14, 4:24 AM ET
GSK's Jideytro Achieves 94% Objective Response Rate At 15.2 Months Follow-Up In TKI-Naïve ROS1-Positive NSCLC, ARROS-1 Trial Shows
NewsSep 8, 7:33 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
NewsSep 7, 1:35 PM ET
8 Health Care Stocks Whale Activity In Today’s Session
NewsSep 4, 2:03 PM ETVandana Singh
Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Report
NewsSep 3, 2:19 PM ETVandana Singh
Why Is HUTCHMED Stock Soaring Thursday?
NewsSep 1, 8:29 AM ETVandana Singh
GSK Says Immune Response from mRNA Flu Shot Surpasses Licensed Competitors
NewsAug 25, 3:40 PM ET
FDA Approves Drug To Treat HIV Infection in Newborns
NewsAug 25, 3:31 PM ETDaragh Thomas
Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?
Press releaseAug 24, 1:05 PM ETPRNewswire
CPE Media & Data Company: Lowest Level of International Venture Capital Funding - Canadian VC H1 2026
NewsAug 24, 1:19 AM ETSnigdha Gairola
Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy
NewsAug 14, 1:35 PM ET
9 Health Care Stocks Whale Activity In Today’s Session
NewsAug 11, 8:39 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
NewsAug 10, 11:01 PM ETRadhika Anilkumar Nadig
Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)
NewsAug 7, 8:36 AM ETNamrata Sen
Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'
NewsJul 28, 1:30 PM ETVandana Singh
GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals
NewsJul 28, 7:38 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
NewsJul 28, 7:19 AM ET
GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate
Press releaseJul 22, 1:58 PM ETPRNewswire
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
NewsJul 22, 1:39 PM ETVandana Singh
FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule
NewsJul 21, 10:13 PM ETRadhika Anilkumar Nadig
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US
NewsJul 17, 10:48 AM ETVandana Singh
Disappointing Data Prompts GSK to Drop Cough Drug Development
NewsJul 14, 7:30 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
NewsJul 5, 2:08 PM ET
Warren Says Trump's Law Pushed 2 Million-Plus Children Off Medicaid, CHIP Across States
NewsJun 9, 1:26 PM ETPiero Cingari
Nasdaq 100 Tumbles Over 3%, Marvell Crashes 12%: Stock Market Today
NewsJun 9, 6:52 AM ETTanya Rawat
GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent
NewsMay 11, 12:03 PM ETVandana Singh
GSK Targets China's Hepatitis B Market Through New Deal
NewsMar 4, 1:00 PM ET
Price Over Earnings Overview: GSK
NewsFeb 4, 2:46 AM ET
GSK Declares Q4 2025 Dividend Of 18p Per Share, Up From 16p In Q3, Payable on 9 April 2026
NewsJan 20, 4:00 PM ET
Price Over Earnings Overview: GSK
NewsAug 27, 5:00 PM ET
Price Over Earnings Overview: GSK
NewsApr 4, 5:00 PM ET
A Look Into GSK Inc's Price Over Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

GSK Wins FDA Approval For Chronic Hepatitis B Drug

Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)

FDA Approves First-Of-Its-Kind Chronic Hepatitis B Treatment; Approves Hibsago (Bepirovirsen) For Chronic Hepatitis B In Adults Without Cirrhosis

Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer

FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated

FDA Approves Immunotherapy That May Allow Certain Patients With Rectal Cancer To Avoid Chemotherapy, Radiation And Surgery

Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push

Viola Davis partners with GSK to educate adults 50 and older about their shingles risk

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Why Is GSK Stock Gaining Monday?

GSK's Jideytro Achieves 94% Objective Response Rate At 15.2 Months Follow-Up In TKI-Naïve ROS1-Positive NSCLC, ARROS-1 Trial Shows

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

8 Health Care Stocks Whale Activity In Today’s Session

Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Report

Why Is HUTCHMED Stock Soaring Thursday?

GSK Says Immune Response from mRNA Flu Shot Surpasses Licensed Competitors

FDA Approves Drug To Treat HIV Infection in Newborns

Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?

CPE Media & Data Company: Lowest Level of International Venture Capital Funding - Canadian VC H1 2026

Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy

9 Health Care Stocks Whale Activity In Today’s Session

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)

Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'

GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule

Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US

Disappointing Data Prompts GSK to Drop Cough Drug Development

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Warren Says Trump's Law Pushed 2 Million-Plus Children Off Medicaid, CHIP Across States

Nasdaq 100 Tumbles Over 3%, Marvell Crashes 12%: Stock Market Today

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent

GSK Targets China's Hepatitis B Market Through New Deal

Price Over Earnings Overview: GSK

GSK Declares Q4 2025 Dividend Of 18p Per Share, Up From 16p In Q3, Payable on 9 April 2026

Price Over Earnings Overview: GSK

Price Over Earnings Overview: GSK

A Look Into GSK Inc's Price Over Earnings